PRESS RELEASE published on 04/04/2025 at 14:00, 1 year 1 month ago Uitstel Gewone Algemene Vergadering Oxurion NV annonce le report de son Assemblée Générale des Actionnaires au 13 mai 2025 en raison de l'indisponibilité de ses états financiers Assemblée Générale États Financiers Report Risques Oxurion NV
PRESS RELEASE published on 04/04/2025 at 14:00, 1 year 1 month ago Postponement Annual Shareholders Meeting Oxurion NV postponed its Annual Shareholders Meeting to May 13, 2025, due to pending annual accounts. The biopharmaceutical company, focused on ophthalmic therapies, is based in Leuven, Belgium Biopharmaceutical Annual Shareholders Meeting Postponed Ophthalmic Therapies Oxurion NV
BRIEF published on 04/02/2025 at 18:05, 1 year 1 month ago Oxurion reçoit une notification de transparence de Atlas Special Opportunities II LLC Actions Transparence Atlas Special Opportunities Oxurion Biopharmacie
BRIEF published on 04/02/2025 at 18:05, 1 year 1 month ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Actions Transparency Atlas Special Opportunities Oxurion Biopharmacy
PRESS RELEASE published on 04/02/2025 at 18:00, 1 year 1 month ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC waaruit blijkt verkoop van aandelen onder drempel. Meer informatie op www.oxurion.com Transparantiekennisgeving Oxurion NV Oftalmologische Therapieën Biofarmaceutisch Bedrijf Atlas Special Opportunities II LLC
PRESS RELEASE published on 04/02/2025 at 18:00, 1 year 1 month ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV, a biopharmaceutical company, received a transparency notification from Atlas Special Opportunities II, LLC regarding shareholding threshold crossing under Belgian legislation Transparency Notification Shareholding Threshold Oxurion NV Belgian Legislation Atlas Special Opportunities II LLC
BRIEF published on 03/27/2025 at 18:05, 1 year 1 month ago Oxurion reçoit une notification de transparence ajustée Actionnariat Notification De Transparence Oxurion Atlas Special Opportunities II Bourse De Bruxelles
BRIEF published on 03/27/2025 at 18:05, 1 year 1 month ago Oxurion receives adjusted transparency notification Transparency Notification Shareholding Oxurion Atlas Special Opportunities II Brussels Stock Exchange
PRESS RELEASE published on 03/27/2025 at 18:00, 1 year 1 month ago Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities II LLC, waardoor zij onder de drempel (5%) komen. Meer informatie beschikbaar op www.oxurion.com Transparantiekennisgeving Oxurion NV Netvliesaandoeningen Biofarmaceutisch Bedrijf Atlas Special Opportunities II LLC
PRESS RELEASE published on 03/27/2025 at 18:00, 1 year 1 month ago Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received an amended transparency notification from Atlas Special Opportunities II, LLC regarding the sale of voting securities. This press release replaces the one from March 18, 2025 Transparency Notification Euronext Brussels Oxurion NV Retinal Disease Therapies Atlas Special Opportunities II
Published on 05/08/2026 at 01:50, 45 minutes ago Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 1 hour 50 minutes ago Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 2 hours 35 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 3 hours 5 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 3 hours 20 minutes ago BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/07/2026 at 23:23, 3 hours 11 minutes ago H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 3 hours 20 minutes ago EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 4 hours 29 minutes ago Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 5 hours 52 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 7 hours 48 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 19:15, 7 hours 20 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 7 hours 20 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 7 hours 28 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 7 hours 28 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 7 hours 35 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
